Explanation |
Criteria achieved |
Validated Part / Validated Contribution |
We created a new BioBrick part as expected : BBa_K2616000. This part permits to secrete proNGF directly in the extracellular medium using E. coli type I secretion system. We used inducible promoter T7, in order to control proNGF production thanks to IPTG induction. We also added an His-tag in N-terminal in order to purify it. proNGF is adressed to Type I Secretion System by fusing to it the the 60 C-terminal aminoacid of alpha-haemolysin HlyA. Since the export peptide is not processed when passing through the secretion pore, we separated proNGF from this 60 aminoacid long sequence by the cleaving site for TEV protease ENLYFQ. This part also permits to secrete TEV protease, under the same promoter, via this same secretion system. |
Collaboration
|
We hosted the 4th Parisian Meet-Up where we organized a Tiny Jamboree in the morning in order to practice with all the French teams for the Giant one in October. We also organized and attended round tables about bioethics with multiple professionals during the afternoon.
We collaborated with other iGEM teams for the Interlab (Sorbonne U Paris), by sharing and testing protocols (WPI Worcester) as well as other non-scientific collaborations. You can read about them on this page .
|
Human Practices
|
We took into account the advice of many professionals in the conception and confinement of our interface NeuronArch. Our juridic team has worked with the Ethical Committee of the Pasteur Institute on the ethical and safety questions surrounding the use of GMOs inside the human body. We have tried to destigmatize the use of GMOs to the general public. Because we also thought about the consequences of a possible release of our GMOs in the environnement, we also integrated a thermosensitive Kill-Switch inside our bacteria. You can read about it on this page.
|